Search Results 851-860 of 17401 for alopecia

1. Audiology - Conditions treated - Mayo Clinic

   Mayo Clinic ear, nose and throat (ENT)/head and neck specialists treat medical conditions that cause hearing loss, dizziness or imbalance and offer a full range ...

2. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

   Note: patients with ≤ grade 2 neuropathy or ≤ grade 2 alopecia or ≤ grade 3 audiometric hearing loss are an exception to this criterion and may qualify for ...

3. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   ... alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the ...

4. Study of CG0070 Given in Combination With Pembrolizumab, in Non Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin - Mayo Clinic

   NOTE: Patients with ≤ Grade 2 neuropathy or having any alopecia are an exception to this criterion and may qualify for the study. NOTE: If patient received ...

5. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   0) due to prior cancer therapy (subjects with alopecia may be enrolled). Has a history or current evidence of any condition, therapy, or laboratory ...

6. Nutrition and healthy eating Healthy diets - Mayo Clinic

   You can master healthy eating by learning how to plan meals and shop smart, and by practicing healthy-cooking techniques.

7. https://www.mayoclinic.org/spanish_organization_concepts.xml

8. A Study to Evaluate the Safety and Therapeutic Activity of GI-102 in Patients With Advanced Solid Tumors - Mayo Clinic

   ... alopecia and Grade 2 peripheral neuropathy. HIV infected patients must be on anti-retroviral therapy (ART) and have a well-controlled HIV infection/disease ...

9. A Study to Evaluate Lasofoxifene versus Fulvestrant in Advanced or Metastatic ER+/HER2− Breast Cancer Patients with an ESR1 Mutation - Mayo Clinic

   Subjects must be free of all chemotherapy acute toxicity excluding alopecia and Grade II peripheral neuropathy before study entry. ECOG performance score of ...

10. Etiology, Prevention and Therapy Navigation of Cancer - Mayo Clinic

    The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...